{"id":"W2301375938","doi":"10.1093/annonc/mdu340.48","title":"Subgroup Analyses of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Trial of Lenvatinib (E7080) in Patients with 131I-Refractory Differentiated Thyroid Cancer","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenvatinib; Medicine; Refractory (planetary science); Placebo; Oncology; Internal medicine; Thyroid cancer; Double blind; Clinical trial; Phases of clinical research; Thyroid; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004327939,0.002493297,0.006444435,0.0006592196,0.0005074641,0.001382624,0.0009429911,0.001734415,0.004098697],"category_scores_gemma":[0.006291762,0.0007720628,0.009376566,0.0007096153,0.000642545,0.00126574,0.0006996501,0.002775622,0.0004525526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001108298,"about_ca_system_score_gemma":0.001251227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001316303,"about_ca_topic_score_gemma":0.004327965,"domain_scores_codex":[0.9976327,0.001300019,0.0003560989,0.0003285292,0.0001675286,0.0002151073],"domain_scores_gemma":[0.9978549,0.001075567,0.0004048347,0.0003149469,0.0001543751,0.0001953323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9353845,0.0006554483,0.001547627,0.002959901,0.04640273,0.0001000347,0.00006459826,0.0005113495,0.001987766,0.0001171797,0.001005638,0.009263233],"study_design_scores_gemma":[0.9055432,0.01694792,0.009065233,0.0001925469,0.06360399,0.0001129615,0.0001065481,0.0009070807,0.0007457089,0.0008711957,0.001836027,0.00006764666],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8800215,0.09730753,0.003001406,0.002071134,0.00311119,0.005260769,0.004866388,0.0003578428,0.004002249],"genre_scores_gemma":[0.9825864,0.007424866,0.001592165,0.001479158,0.0006639637,0.002576993,0.001846221,0.00005022993,0.001780239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006444435,"threshold_uncertainty_score":0.0228886,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1023451186311762,"score_gpt":0.4283035591414361,"score_spread":0.3259584405102599,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}